Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days to obtain the report for the Lung Fusions Panel by NGS is typically 14-21 days. This timeframe includes the time for sample collection, processing, sequencing, data analysis, and report generation.

What are the prerequisites for the test Lung Fusions Panel by NGS

  • Patient's consent for genetic testing
  • Requisition form filled out completely
  • Specimen type: FFPE tissue block or 10 unstained slides with at least 20% tumor cells
  • Specimen stability: Specimens must be received within 5 days of collection
  • Specimen storage: Specimens must be stored at room temperature
  • Specimen transport: Specimens must be shipped overnight at room temperature

What are the measure values for the test Lung Fusions Panel by NGS

  • Fusion Name: The name of the fusion gene detected
  • Gene 1: The first gene involved in the fusion
  • Gene 2: The second gene involved in the fusion
  • Junction Read Count: The number of reads supporting the fusion junction
  • Spanning Fragments: The number of reads spanning the fusion breakpoint
  • Allele Frequency: The frequency of the fusion allele in the sample

What does this test Lung Fusions Panel by NGS identify?

Lung Fusions Panel by NGS

The Lung Fusions Panel by NGS is a genetic test that identifies specific fusion genes in lung cancer cells. These fusion genes are formed when two different genes join together, often as a result of chromosomal rearrangements. The identification of these fusion genes can help in diagnosing and treating lung cancer.

Some of the fusion genes that are commonly tested for in the Lung Fusions Panel include ALK, ROS1, RET, and NTRK. These fusion genes are known to be drivers of lung cancer and can be targeted with specific therapies such as tyrosine kinase inhibitors.

Overall, the Lung Fusions Panel by NGS helps in identifying specific genetic abnormalities in lung cancer cells, which can guide treatment decisions and improve patient outcomes.

Why is this test Lung Fusions Panel by NGS taken?

The Lung Fusions Panel by NGS test is taken to detect genetic abnormalities in lung cancer patients. This test uses Next-Generation Sequencing (NGS) technology to identify gene fusions that may be driving the growth of lung cancer cells.

Gene fusions are abnormal genetic events that occur when two different genes become fused together. In some cases, these fusions can lead to the development and progression of cancer. By identifying specific gene fusions in lung cancer patients, doctors can determine the most effective treatment options, such as targeted therapies that specifically target the fusion gene.

Overall, the Lung Fusions Panel by NGS test helps oncologists personalize treatment plans for lung cancer patients by providing valuable information about the genetic makeup of their tumors. This can lead to more effective and targeted treatments, ultimately improving patient outcomes.

No FAQs available.

Customer Google Rating